FDA Warns Medline Electric Hospital Beds Can Overheat, Linked to 2 Deaths

The alert activates federal product safety review processes that can compel recalls, and it places Medline's regulatory standing under scrutiny at a moment when hospital procurement decisions...

The U.S. Food and Drug Administration issued an urgent safety alert warning that motorized electric beds manufactured by Medline Industries can overheat and cause fires, a hazard the agency linked to two deaths, according to a CBS News report published October 30, 2026.

The FDA alert, classified as urgent, directed the warning to consumers and healthcare facilities using Medline's motorized bed products. The agency stated the beds' electrical components can overheat, creating a fire risk. The specific model numbers and the total number of units distributed have not been confirmed in publicly available FDA documentation reviewed at the time of publication. The FDA's MedWatch database and the agency's medical device recall database are the records that would specify affected model ranges and distribution volumes.

Medline Industries is a privately held medical supply company headquartered in Northfield, Illinois. It is one of the largest manufacturers and distributors of healthcare supplies in the United States, supplying equipment to hospitals, nursing homes, and home care patients. Because Medline is privately held, its annual revenue figures are not filed with the Securities and Exchange Commission. The company has not issued a public statement on the FDA alert that was available in verified public records as of October 30, 2026.

Under the Federal Food, Drug, and Cosmetic Act, the FDA has authority to request or order recalls of medical devices that present an unreasonable risk of substantial harm. An urgent safety alert is a formal step in that process and can precede a mandatory recall order if the manufacturer does not act voluntarily. The agency grades recalls on a Class I, II, or III scale, with Class I reserved for situations where use of the product is likely to cause serious injury or death. The classification of the Medline bed alert had not been publicly posted in the FDA recall database as of this report.

The two deaths cited in the FDA alert represent the most serious category of adverse event reportable under the Medical Device Reporting regulation, codified at 21 CFR Part 803. Hospitals and device manufacturers are legally required to submit reports to the FDA when a device is suspected of contributing to a death or serious injury. Whether the two deaths were reported by Medline, by a healthcare facility, or by another party is not stated in currently available public records. The FDA's MAUDE (Manufacturer and User Facility Device Experience) database would contain those adverse event reports if they have been made public.

Electric hospital beds are classified as Class II medical devices under FDA regulations, meaning they require 510(k) premarket notification clearance before sale. Class II devices are subject to special controls, which can include performance standards, postmarket surveillance, and patient registries. The specific 510(k) clearance numbers associated with the affected Medline bed models were not identified in public records available at the time of this report.

Federal procurement records on USASpending.gov show that the federal government, including the Department of Veterans Affairs and the Department of Defense, purchases hospital beds and related medical equipment through supply contracts. Whether any active federal contracts cover the specific Medline bed models named in the FDA alert is unknown. The Federal Procurement Data System would contain that information.

Congress has oversight authority over FDA enforcement actions through the House Energy and Commerce Committee and the Senate Health, Education, Labor, and Pensions Committee. Neither committee had issued a public statement or announced a hearing related to the Medline alert as of October 30, 2026.

Comparable FDA urgent alerts for hospital bed fire hazards have resulted in Class I recalls in prior years. In 2019, the FDA issued a Class I recall for a separate manufacturer's electric bed product over an overheating risk, according to the FDA recall database. That recall affected tens of thousands of units. Whether the Medline situation will follow the same regulatory path depends on the company's response to the alert and the FDA's subsequent review, neither of which had been publicly documented as of this report.

What remains unknown includes the specific Medline bed models covered by the alert, the number of units in distribution, the circumstances of the two deaths, whether Medline has initiated a voluntary recall, and the FDA's planned next enforcement step. The FDA's medical device recall database, the MAUDE adverse event database, and any forthcoming Medline public statement would provide answers to those questions.